As part of Osiris's territorial stake on the mesenchymal stem cell area, this patent covers antibodies that are publically available from ATCC, that specifically recognize mesenchymal stem cells.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.